版本:
中国

BRIEF-HBM Healthcare Investments FY net profit up at CHF 136.8 million

May 16 HBM HEALTHCARE INVESTMENTS AG:

* PROPOSING AN INCREASE IN THE CASH DIVIDEND OF 30 CENTIMES, TO CHF 5.80 PER SHARE

* EXPECTS THE LUTATHERA CANCER DRUG TO BE APPROVED TOWARDS THE END OF 2017

* FY NET PROFIT OF CHF 136.8 MILLION VERSUS CHF 23.8 MILLION YEAR AGO

* WILL CONTINUE TO MAKE SHAREHOLDER-FRIENDLY DISTRIBUTIONS AND SHARE BUY-BACKS Source text: bit.ly/2qmfmE3 Further company coverage: (Gdynia Newsroom)

我们的标准: 汤森路透“信任原则

更多 瑞士市场报道

热门文章

编辑推荐

文章推荐